New methods to reduce itching from burn scars
Official title: Novel Strategies for Reducing Burn Scar Itch
Run by The University of Texas Medical Branch, Galveston · NCT06801626 · Data updated 2026-11-12
This study is testing whether diphenhydramine, famotidine, and cromolyn sodium can help adults with burn scars feel less itchy.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 44 (estimated) |
| Sponsor | The University of Texas Medical Branch, Galveston Academic / other |
| Drugs / interventions | dasatinib, neratinib |
| Locations | 1 site (Galveston, Texas) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | November 1, 2028 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT06801626 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 80 who have an itchy burn scar.
✕Probably not a fit
Patients with medical conditions that increase their risk or those unable to comply with study protocols may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of diphenhydramine, famotidine, and cromolyn sodium in alleviating itch associated with burn scars. Participants will be divided into two groups to compare the effects of oral diphenhydramine with either a placebo or with famotidine and topical cromolyn sodium. The goal is to determine if these medications can significantly reduce itchiness in adults suffering from burn scars. The study is designed to provide insights into new treatment options for this common and distressing symptom.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment for patients suffering from itch due to burn scars.
How similar studies have gone: Previous studies have shown that similar medications can reduce itch in other patient populations, suggesting potential success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants must meet all the inclusion criteria in order to be eligible to participate in the study. * Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures. * Adults: ≥18 to \<80 years of age. * Has an itchy burn scar. Exclusion Criteria: Participants meeting any of the exclusion criteria at baseline will be excluded from study participation. * Failure to obtain consent or unable to return for follow up assessments. * Patient is unable to follow the protocol required assessments. * Member of a vulnerable class (e.g., prisoners, pregnant participant, etc.). * Any medical condition that, in the opinion of the investigator or physician, would place the participant at increased risk for participation. * Concurrent participation in another interventional clinical trial (to avoid confounding factors that may influence outcomes). * History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the participant to comply with the study procedures or follow the investigators instructions. * Age \< 18 or ≥ 80 years. * Taking one of the following medications: cefuroxime, dasatinib, delavirdine, neratinib, pazopanib, risedronate, or tizanidine. * Has a pre-existing inflammatory or itchy skin disease. * Is taking an H2 antihistamine for another indication.
Where it's running
-
University of Texas Medical Branch, Galveston
Galveston, Texas, United States Recruiting
Study contacts
- Principal investigator: Celeste Finnerty, PhD — University of Texas Medical Branch, Galveston
- Study coordinator: Celeste Finnerty, PhD
- Email: ccfinner@utmb.edu
- Phone: 409-692-9036
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cold plasma treatment for chronic wounds in adults
This study tests whether cold plasma applied with helium and dressings infused with plasma-induced ions can help healing in adults with chronic leg or other vascular wounds.
-
Miro3D tissue scaffold for complex soft-tissue wounds and pressure ulcers
This trial will test whether adding the Miro3D tissue scaffold to usual wound care helps adults with complex soft-tissue wounds or chronic pressure ulcers heal faster over 12 weeks.
-
Remimazolam versus propofol for sedation during fractional CO₂ laser treatment of burn scars
This will test whether remimazolam or propofol leads to fewer breathing problems and faster recovery for adults having fractional CO₂ laser treatment for burn scars.
-
Cyanoacrylate glue versus collagen sponge for healing palatal donor wounds
This test compares cyanoacrylate glue (PeriAcryl) and collagen sponge to see which helps adult patients' palatal donor sites heal faster and feel more comfortable after a free gingival graft.
-
Amnion grafts for hard-to-heal diabetic foot and venous leg ulcers
This study will test whether two types of amnion grafts, added to standard wound care, help hard-to-heal diabetic foot and venous leg ulcers heal better.
-
Using Negative Pressure Therapy to Prevent Infections in Surgical Wounds
This study is testing if using Negative Pressure Therapy can help prevent infections in surgical wounds for people who have had laparotomy surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.